Therapeutic potential of isozyme-selective phosphodiesterase inhibitors in the treatment of asthma.

Autor: Torphy TJ; Department of Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406., Livi GP, Balcarek JM, White JR, Chilton FH, Undem BJ
Jazyk: angličtina
Zdroj: Advances in second messenger and phosphoprotein research [Adv Second Messenger Phosphoprotein Res] 1992; Vol. 25, pp. 289-305.
Databáze: MEDLINE